VWF and thrombotic disease: Inhibiting VWF improves the outcome in patients with thrombotic thrombocytopenic purpura32,33, but it could also offer potential benefits for patients suffering from stroke38, myocardial infarction3, or other thrombotic diseases such as sickle cell disease43.